Literature DB >> 20877679

Evidence-Based Complementary Medicine in Breast Cancer Therapy.

Josef Beuth1.   

Abstract

Complementary medicine is currently widely debated by the oncologic community, because the required scientific proof of safety and effectiveness for most of the therapeutic approaches ha s not yet been met with definite results. In the past years, basic research and clinical evaluation of defined complementary therapeutic concepts in oncology have been intensified in an attempt to integrate these procedures into evidence-based medicine. According to definition, scientifically-based therapies of complementary medicine cannot replace the well-studied conventional cancer-destructive therapies such as surgery, chemotherapy, radiotherapy, or hormone therapy. Complementary approaches in oncology that are recommended as an addition to standard cancer-destructive therapies claim to optimize this therapy. A great body of data emerging from scientifically sound clinical trials prove that defined complementary procedures are beneficial for the patients.

Entities:  

Year:  2009        PMID: 20877679      PMCID: PMC2942012          DOI: 10.1159/000194306

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  21 in total

1.  Evidence of altered structural and secretory glycoconjugates in the jejunal mucosa of patients with gluten sensitive enteropathy and subtotal villous atrophy.

Authors:  M Vecchi; G Torgano; R de Franchis; S Tronconi; D Agape; G Ronchi
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

2.  Reduction of postoperative lymphedema after oral tumor surgery with sodium selenite.

Authors:  Thomas Zimmermann; Henry Leonhardt; S Kersting; S Albrecht; U Range; Uwe Eckelt
Journal:  Biol Trace Elem Res       Date:  2005-09       Impact factor: 3.738

3.  Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

Authors:  Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2006-07-05       Impact factor: 44.544

4.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

5.  Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study.

Authors:  J Beuth; B Ost; A Pakdaman; E Rethfeldt; P R Bock; J Hanisch; B Schneider
Journal:  Cancer Chemother Pharmacol       Date:  2001-07       Impact factor: 3.333

Review 6.  Review. Evidence-based complementary oncology. Innovative approaches to optimize standard therapy strategies.

Authors:  Josef Beuth; Joerg Michael Schierholz
Journal:  In Vivo       Date:  2007 Mar-Apr       Impact factor: 2.155

7.  Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.

Authors:  B K Piao; Y X Wang; G R Xie; U Mansmann; H Matthes; J Beuth; H S Lin
Journal:  Anticancer Res       Date:  2004 Jan-Feb       Impact factor: 2.480

8.  Selenium in the treatment of head and neck lymphedema.

Authors:  F Bruns; J Büntzel; R Mücke; K Schönekaes; K Kisters; O Micke
Journal:  Med Princ Pract       Date:  2004 Jul-Aug       Impact factor: 1.927

9.  The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.

Authors:  V F Semiglasov; V V Stepula; A Dudov; W Lehmacher; U Mengs
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

10.  Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.

Authors:  K Schumacher; B Schneider; G Reich; T Stiefel; G Stoll; P R Bock; J Hanisch; J Beuth
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

View more
  7 in total

1.  Complementary Methods in Breast Cancer Therapy.

Authors:  Volker Hanf
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

Review 2.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 3.  Commonly used methods of complementary medicine in the treatment of breast cancer.

Authors:  Jutta Hübner; Volker Hanf
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

Review 4.  Preclinical and clinical effects of mistletoe against breast cancer.

Authors:  Mohsen Marvibaigi; Eko Supriyanto; Neda Amini; Fadzilah Adibah Abdul Majid; Saravana Kumar Jaganathan
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 5.  Breast Cancer Research to Support Evidence-Based Medicine in Nigeria: A Review of the Literature.

Authors:  Omolara A Fatiregun; Temiloluwa Oluokun; Nwamaka N Lasebikan; Emmanuella Nwachukwu; Abiola A Ibraheem; Olufunmilayo Olopade
Journal:  JCO Glob Oncol       Date:  2021-03

6.  An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.

Authors:  Oktay Tarhan; Ugur Muslu; Isil Somali; Cigdem Erten; Ahmet Alacacioglu; Sengul Varol; Leyla Aslan
Journal:  Breast Care (Basel)       Date:  2009-10-01       Impact factor: 2.860

7.  Integrative oncology for breast cancer patients: introduction of an expert-based model.

Authors:  Gustav J Dobos; Petra Voiss; Ilka Schwidde; Kyung-Eun Choi; Anna Paul; Barbara Kirschbaum; Felix J Saha; Sherko Kuemmel
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.